Off label treatments of genital warts: the role of photodynamic therapy.

G Ital Dermatol Venereol

Sexually Transmitted Disease and AIDS Center, Unit of Clinical Dermatology, University of Florence, Florence, Italy.

Published: October 2012

Conventional therapies for genital warts, the clinical expression of low-risk human papillomavirus (HPV) anogenital infection, are not targeted antiviral therapies, but either attempt physical removal of the lesion or induce inflammation and a bystander immune response. Moreover, very few of the current treatments have been tested by rigorous blinded, randomized controlled trials. Therefore, official recommendations are often associated with unsatisfactory response rates and high recurrence rates. It is the purpose of this review to provide a brief overview of the genital wart treatment literature to expand awareness of the options available to practitioners faced with patients presenting with this disease. Particular attention will be paid to unconventional and complementary therapies (the so called "off-label" treatments) among which photodynamic therapy has been recently introduced as a promising strategy to both guarantee clearance of the lesion and eradication of the virus itself. Mechanisms of action of PDT are discussed together with a summary of clinical and experimental available evidences.

Download full-text PDF

Source

Publication Analysis

Top Keywords

genital warts
8
photodynamic therapy
8
label treatments
4
treatments genital
4
warts role
4
role photodynamic
4
therapy conventional
4
conventional therapies
4
therapies genital
4
warts clinical
4

Similar Publications

Population-level Impact of HPV Vaccination on the Incidence of Genital Warts in Sweden.

J Infect Dis

January 2025

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, SE-17177 Stockholm, Sweden.

Background: Sweden introduced HPV vaccination in 2006, administered through opportunistic, subsidized, catch-up and school-based programs. Notably, genital warts (GW) are the first observable clinical outcome following infection by HPV-6/11, targeted by vaccination. We aim to gain knowledge of the incidence of GW in Sweden and evaluate its change throughout vaccination programs.

View Article and Find Full Text PDF

Background: Human papillomavirus (HPV) is a common infection of the anogenital tract. Although most infections clear, persistent infections with oncogenic types can predispose to cancer. While the natural history of anogenital HPV infection in cisgendered women is relatively well understood, there are significant knowledge gaps regarding HPV prevalence and clinical implications of genital HPV infection in transgender women (TGW) with neovagina(s).

View Article and Find Full Text PDF

Human papillomavirus (HPV) infections rank as the most prevalent sexually transmitted infections globally. The Brazilian Ministry of Health recommends the topical use of 70%-90% trichloroacetic acid (TAA) for treating condyloma acuminata, yet this method suffers from a high recurrence rate of 36% and requires roughly six applications. Topical photodynamic therapy (PDT) has shown effectiveness in targeting subclinical lesions, but it also necessitates multiple sessions for complete lesion clearance.

View Article and Find Full Text PDF

Approximately 80 million US adults-one in four-are infected with the human papillomavirus (HPV), which causes cancers of the cervix in women, cancers of the anus, penis, and throat in men, and genital warts in both sexes. Although HPV vaccinations are safe, effective, easily affordable, and readily available, a substantial percentage of parents resist recommendations to vaccinate their children against HPV. The current study tests the effects of different vaccination advocacy message strategies on attitudes toward HPV vaccination.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!